Active management of third stage of labour, post–partum haemorrhage and maternal death rate in the Vanga Health Zone, Province of Bandundu, Democratic Republic of the Congo
Abstract
Objectives: To describe the practice of AMTSL in Vanga Health Zone and to calculate the incidence of PPH in Vanga Health Zone.
Method: An intervention study with post-test-only design was conducted among health maternity wards using a data collection sheet to obtain information. All pregnant women attending Vanga Health maternity wards constituted the study population. Frequencies were determined for variables of interest.
Results: From April 2007 to March 2008, 6339 deliveries took place at Vanga Health maternity wards, representing 71% of the institutional delivery rate. The number of deliveries realised with the practice of (AMTSL) were 5562; 366 cases of PPH were reported, making an incidence of 5.77%. Three cases of maternal deaths – two of which were related to PPH – were reported during the study period, which means there was a decline of 70% compared with the previous two years.
Conclusion: The prevalence of PPH has been estimated to be 5.77%; PPH represents the cause of 67% of all maternal deaths. The extension of AMTSL practice, combined with the assurance of better supplies of oxytocin to enhance drug management, is strongly advised/suggested. As a number of births still take place outside the health maternity wards, the introduction of oral misoprostol could be considered a part of AMTSL for use by patients being treated by traditional midwives.
How to cite this article: Fina Lubaki J-P, Musiti Ngolo J-R, Zikudieka Maniati L. Active management of third stage of labour, post–partum haemorrhage and maternal death rate in the Vanga Health Zone, Province of Bandundu, Democratic Republic of the Congo. Afr J Prm Health Care Fam Med. 2010;2(1), Art. #76,3 pages. DOI: 10.4102/phcfm.v2i1.76
References
AbouZahr C. Global burden of maternal death and disability. British Medical Bulletin. 2003;67:1–11.
World Health Organization. Maternal Mortality: A Global Factbook. Geneva: WHO; 1991.
Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: A systematic review. Lancet. 2006;367:1066−1074.
Zone de santé rurale de Vanga. Rapport annuel 2006. Vanga: ZSV; 2007.
Zone de santé rurale de Vanga. Rapport annuel 2007. Vanga: ZSV; 2008.
Prendiville WJ, Elbourne D. Care during the third stage of labor. In: Chalmers I, Enkin M, Keirse MJNC, editors. Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1998; p. 1145–1169.
World Health Organization (WHO). Mother-Baby Package: Implementing Safe Motherhood in Countries. Geneva: WHO; 1998.
AbouZahr. Antepartum and post–partum haemorrhage. In: Murray CJL, Lopez AD, editors. Health dimensions of sex and reproduction: The global burden of sexually transmitted diseases, maternal conditions, perinatal disorders, and congenital anomalies. Geneva: WHO, 1998; p. 165–190.
Akins S. Postpartum haemorrhage. A 90s approach to an age-old problem. J Nurse Midwifery. 1994;39:123S−134S.
McCormick M, Sanghvi H, Kinzie B, McIntosh N. Preventing postpartum hemorrhage in low–resource settings. Int J Gynaecol Obstet. 2002;77:267–275.
FIGO ICM Joint Statement. Management of third stage of labour to prevent post-partum Haemorrhage. 2003.
WHO recommendations for the prevention of postpartum haemorrhage. Geneva: WHO; 2007.
Gülmezoglu AM et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet. 2001;358:689−695.
Bagley C. A comparison of active and expectant management of the third stage of labour. Midwifery. 1990;6:3–27.
Khan GQ. Controlled cord traction versus minimal interventions techniques in delivery of the placenta: A randomized controlled trial. Am J Obstet Gynecol. 1997;177:770–774.
Prendiville WJ, Elbourne D, Chalmers I. The effects of routine oxytocic administration in the management of third stage of labour: An overview of the evidence from controlled trials. Br J Obstet Gynaec. 1998;95:3–16.
Rogers J, Wood J, McCandlish et al. Active versus expectant management of third stage of labour: The Hinchingbrooke randomised controlled trial. Lancet. 1998;351:693–699.
Prendiville W, Elbourne D, McDonald S. 2003. Active versus expectant management of the third stage of labour. [Cochrane Review] In: The Cochrane Library, Issue 3, 2003. Chichester, Update Software.
Thaddeus S, Nangalia R. Perceptions Matter: Barriers to treatment of post-partum haemorrhage. J Midwifery Womens Health. 2004;49(4):293–297.
Sanghvi H, Lewison D, editors. Report of a conference in Entebbe. Preventing Mortality from post partum hemorrhage in Africa: Moving from Research to Practice; 2006 April 4−7; Entebbe, Uganda. JHPIEGO, Baltimore; 2006.
Leedy P. Practical research: planning and design. Columbus: Merrill; 1997.
Bowling A. Research methods in health: Investigating health and health services. Oxford: Oxford University Press; 2002.
Nilses C, Nyström L, Munjanja S, Lindmark G. Self-reported reproductive outcome and implications in relation to use of care in women in rural Zimbabwe. Acta Obstet Gynecol Scand. 2002;81(6):508–515.
Nwakoby BN. Use of obstetric services in rural Nigeria. J R Soc Health. 1994;114(3):132–136.
Martey JO, Djan JO, Twum S, Browne EN, Opoku SA. Maternal mortality due to post-partum haemorrhage. Int J Gynaecol Obstet. 1993;42(3):237–241.
Goldberg AB, Greenberg MA, Darney PD. Misoprostol and pregnancy. N Engl J Med. 2001;344:38–47.
Full Text: PDF (235 KB) HTML XML

